About the Menopause Research & Equity Act of 2023

Currently, 50 million women in the U.S. are between the ages of 42 and 58 (mid-life), the typical age group who experience physical changes caused by menopause. Of this group, 85% report experiencing menopause-related symptoms (NIH National Library of Medicine).

Women are in Menopause in the United States making up 20 percent of the workforce; overall 75 million women are in perimenopause, menopause and post-menopausal

75 percent of women who seek care are left untreated by their doctors

Legislative Solution: Refocus the NIH to invest in menopause research, mid-life women’s health research, and finding new treatments for the symptoms of menopause. Provide funding certainty so new, long-term research can be conducted.

What the Bill Does:

• Directs the Director of NIH to evaluate the results of completed and ongoing menopause research, and research on mid-life women’s health

• Directs the NIH to determine the safety and effectiveness of treatments for women who experience menopause-related symptoms.

• Directs the NIH to identify the total amount of funding allocated for menopause-related research, and research on mid-life women’s health over the previous 5 fiscal years.

• Directs the NIH to identify and gaps in knowledge or research of the above.

• Requires the NIH to submit a report to Congress on the findings of the evaluation detailed above.

• Requires the NIH to submit a strategic plan to resolve the gaps in knowledge and identify topics of future research relating to potential treatments for menopause-related symptoms.

•  The Menopause Research Equity Act would require the Director of the National Institutes of Health (NIH) to determine the amount of funding allocated by the NIH for such research over the past five fiscal years and to submit a report with their findings and a strategic plan to address the identified gaps in knowledge and research, to Congress within 180 days of enactment.  

Sign up for Updates

Sign up here to learn more about the Menopause Bill in Congress and find out how you can be a part of it.

Members of Menopause Advocacy Working Group 

Dr. Kelly Casperson, MD, Urologist

Samara Daly, Co-Founder and Board Chair, Let’s Talk Menopause

Claire Gill, Founder, National Menopause Foundation; CEO, National Osteoporosis Foundation

Sally Greenberg, JD, Executive Director of The National Consumers League

Tamsen Fadal, Journalist; author; menopause advocate; Let’s Talk Menopause Board Member, LTM Ambassador

Dr. Sheryl Kinsberg, PhD, Chief of Behavioral Medicine, University Hospital Cleveland Medical Center

Donna Klassen, LCSW, Co-Founder & CEO, Let’s Talk Menopause

Dr. Lisa Larkin, MD, FACP, MSCP, Founder and CEO, Ms. Medicine

Jessica Levin, JD, Chief Program Officer, Let’s Talk Menopause

Dr. Sharon Malone, MD, OB/GYN; Chief Medical Advisor to Alloy

Dr. Mary Jane Minkin, MD, OB/GYN, Clinical Professor, Yale Medical School

Dr. Robin Noble, MD, GYN, Medical Director, Intermed; Chief Medical Advisor, Let’s Talk Menopause

Cathy Rought Jacobson, Board Member, Let’s Talk Menopause

Dr. Rachel Rubin, MD, Urologist; Sexual Medicine Specialist; Education Chair for The International Society for the Study of Women’s Sexual Health (ISSWSH)

Omnisade Burney-Scott, Creator, Black Girl’s Guide to Surviving Menopause

Jennifer Weiss-Wolf, JD, Executive Director of NYU’s Law’s Birnbaum Women’s Leadership Center; author/advocate